List of Figures
List of Figures
- Figure 1: Global Cystic Fibrosis Lung Disease Market Size, By Value, 2019-2022 (USD Billion)
- Figure 2: Global Cystic Fibrosis Lung Disease Market Size, By Value, 2023-2029 (USD Billion)
- Figure 3: Global Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
- Figure 4: Global Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 5: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By CFTR modulators, 2019-2029 (USD Billion)
- Figure 6: Global Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 7: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Bronchodilators, 2019-2029 (USD Billion)
- Figure 8: Global Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 9: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Mucolytics, 2019-2029 (USD Billion)
- Figure 10: Global Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 11: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Anti infectives, 2019-2029 (USD Billion)
- Figure 12: Global Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 13: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Oral, 2019-2029 (USD Billion)
- Figure 14: Global Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 15: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Inhalation, 2019-2029 (USD Billion)
- Figure 16: Global Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)`
- Figure 17: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Intravenous, 2019-2029 (USD Billion)
- Figure 18: Global Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 19: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Hospital Pharmacies, 2019-2029 (USD Billion)
- Figure 20: Global Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 21: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Retail Pharmacies, 2019-2029 (USD Billion)
- Figure 22: Global Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 23: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Online Channel, 2019-2029 (USD Billion)
- Figure 24: Americas Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
- Figure 25: Americas Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
- Figure 26: Americas Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 27: Americas Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 28: Americas Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 29: Americas Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 30: Americas Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 31: Americas Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 32: Americas Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 33: Americas Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 34: Americas Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 35: Americas Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 36: United States Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 37: United States Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
- Figure 38: United States Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 39: United States Cystic Fibrosis Lung Disease Market Share, By Route of Administration, By Value, 2022 (%)
- Figure 40: United States Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 41: Canada Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 42: Canada Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
- Figure 43: Canada Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 44: Canada Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 45: Canada Cystic Fibrosis Lung Disease Market Share, Distribution Channel, 2022 (%)
- Figure 46: Rest of Americas Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 47: Rest of Americas Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
- Figure 48: Rest of Americas Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 49: Rest of Americas Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 50: Rest of Americas Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 51: Europe Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
- Figure 52: Europe Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
- Figure 53: Europe Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 54: Europe Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 55: Europe Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 56: Europe Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 57: Europe Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 58: Europe Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 59: Europe Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 60: Europe Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 61: Europe Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 62: Europe Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 63: Germany Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 64: Germany Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
- Figure 65: Germany Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 66: Germany Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 67: Germany Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 68: United Kingdom Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 69: United Kingdom Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
- Figure 70: United Kingdom Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 71: United Kingdom Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 72: United Kingdom Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 73: France Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 74: France Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
- Figure 75: France Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 76: France Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 77: France Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 78: Italy Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 79: Italy Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
- Figure 80: Italy Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 81: Italy Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 82: Italy Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 83: Spain Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 84: Spain Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
- Figure 85: Spain Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 86: Spain Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 87: Spain Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 88: Rest of Europe Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 89: Rest of Europe Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
- Figure 90: Rest of Europe Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 91: Rest of Europe Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 92: Rest of Europe Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 93: Asia Pacific Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
- Figure 94: Asia Pacific Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
- Figure 95: Asia Pacific Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 96: Asia Pacific Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 97: Asia Pacific Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 98: Asia Pacific Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 99: Asia Pacific Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 100: Asia Pacific Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 101: Asia Pacific Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 102: Asia Pacific Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 103: Asia Pacific Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 104: Asia Pacific Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 105: China Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 106: China Cystic Fibrosis Lung Disease Market Value, By Route of Administration, 2022 (USD Million)
- Figure 107: China Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 108: China Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 109: China Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 110: Australia Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 111: Australia Cystic Fibrosis Lung Disease Market Value, By Route of Administration, 2022 (USD Million)
- Figure 112: Australia Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 113: Australia Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 114: Australia Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 115: India Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 116: India Cystic Fibrosis Lung Disease Market Value, By Route of Administration, 2022 (USD Million)
- Figure 117: India Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 118: India Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 119: India Cystic Fibrosis Lung Disease Market Share, Distribution Channel, 2022 (%)
- Figure 120: Rest of Asia Pacific Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
- Figure 121: Rest of Asia Pacific Cystic Fibrosis Lung Disease Market Value, By Route of Administration, 2022 (USD Million)
- Figure 122: Rest of Asia Pacific Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
- Figure 123: Rest of Asia Pacific Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
- Figure 124: Rest of Asia Pacific Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
- Figure 125: Middle East and Africa Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
- Figure 126: Middle East and Africa Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
- Figure 127: Middle East and Africa Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 128: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 129: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 130: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 131: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 132: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 133: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 134: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 135: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 136: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
- Figure 137: Market Share of Prominent Companies of Cystic Fibrosis Lung Disease Market, 2022 (%)
- Figure 138: Vertex Pharmaceuticals Revenue, 2020-2022 (USD Billion)
- Figure 139: Vertex Pharmaceuticals Revenue , By Products, 2022 (%)
- Figure 140: Vertex Pharmaceuticals , By Geographic Segment, 2022 (%)
- Figure 141: GSK PLC Revenue, 2020-2022 (USD Million)
- Figure 142: GSK PLC Revenue , By Business Segments, 2022 (%)
- Figure 143: GSK PLC Revenue, By Geography Segment, 2022 (%)
- Figure 144: Novartis Revenue, 2020-2022 (USD Billion)
- Figure 145: Novartis Revenue, By Business Segments, 2022 (%)
- Figure 146: Novartis Revenue, By Geographical Segments, 2022 (%)
- Figure 147: Roche Revenue, 2020-2022 (USD Billion)
- Figure 148: Roche Revenue, By Business Segments, 2022 (%)
- Figure 149: Roche Revenue, By Business Segments, 2022 (%)
- Figure 150: Bayer AG Revenues, 2020-2022 (USD Million)
- Figure 151: Bayer AG Revenues, By Geographic Segments, 2022 (%)
- Figure 152: Bayer AG Revenues, By Business Segments, 2022 (%)
- Figure 153: Gilead Sciences, Inc. Revenues, 2020-2022 (USD Million)
- Figure 154: Gilead Sciences, Inc. Revenues, By Geographic Segments, 2022 (%)
- Figure 155: Gilead Sciences, Inc. Revenue, By Therapeutic Area, 2022 (%)
List of Tables
Table A1: Cystic fibrosis Therapeutics in the pipeline
Table A2: Cystic fibrosis Small molecule therapies and their targeted mutations
Table A3: Non-viral vectors commonly used for gene and drug delivery in CF patients
Table A4: United States Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A5: United States Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A6: United States Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A7: United States Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A8: United States Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A9: United States Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A10: Canada Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A11: Canada Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A12: Canada Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A13: Canada Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A14: Canada Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A15: Canada Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A16: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A17: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A18: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A19: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A20: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A21: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A22: Germany Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A23: Germany Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A24: Germany Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A25: Germany Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A26: Germany Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A27: Germany Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A28: United Kingdom Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A29: United Kingdom Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A30: United Kingdom Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A31: United Kingdom Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A32: United Kingdom Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A33: United Kingdom Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A34: France Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A35: France Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A36: France Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A37: France Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A38: France Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A39: France Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A40: Italy Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A41: Italy Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A42: Italy Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A43: Italy Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A44: Italy Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A45: Italy Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A46: Spain Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A47: Spain Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A48: Spain Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A49: Spain Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A50: Spain Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A51: Spain Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A52: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A53: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A54: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A55: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A56: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A57: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A58: China Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A59: China Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A60: China Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A61: China Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A62: China Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A63: China Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A64: Australia Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A65: Australia Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A66: Australia Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A67: Australia Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A68: Australia Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A69: Australia Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A70: India Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A71: India Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A72: India Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A73: India Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A74: India Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A75: India Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A76: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A77: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A78: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A79: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A80: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A81: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A82: Vertex Pharmaceuticals Key Company Financials, 2020-2022
Table A83: GSK PLC Key Company Financials, 2020-2022
Table A84: Novartis Key Company Financials, 2020-2022
Table A85: Roche Key Company Financials, 2020-2022
Table A86: Bayer AG Key Financials, 2020-2022
Table A87: Gilead Sciences, Inc. Key Financials, 2020-2022